Title
|
|
|
|
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines
|
|
Author
|
|
|
|
|
|
Abstract
|
|
|
|
With the availability of the nonavalent human papillomavirus (HPV) vaccine, vaccinees, parents and healthcare providers need guidance on how to complete an immunization course started with the bi- or quadrivalent vaccine and whether to revaccinate individuals who have completed a full immunization course with the bi- or quadrivalent vaccine. To answer these questions three parameters should be considered: age at the start of vaccination (9 to 14 years of age versus 15 years and older, the cut-off for 2 or 3 doses schedule), the number of doses already received and the time interval between doses. Based on a number of scenarios, we propose that the 9-valent vaccine can be used to complete an incomplete vaccination regimen or might be added to a previous completed schedule to extend protection. (C) 2016 The Authors. Published by Elsevier Ltd. |
|
|
Language
|
|
|
|
English
|
|
Source (journal)
|
|
|
|
Vaccine / International Society for Vaccines. - Amsterdam
|
|
Publication
|
|
|
|
Amsterdam
:
2016
|
|
ISSN
|
|
|
|
0264-410X
|
|
DOI
|
|
|
|
10.1016/J.VACCINE.2015.12.063
|
|
Volume/pages
|
|
|
|
34
:6
(2016)
, p. 757-761
|
|
ISI
|
|
|
|
000370108500007
|
|
Pubmed ID
|
|
|
|
26772631
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|